
CVLB
Healthcare · Pharmaceutical Retailers · $703.2M market cap
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2020
EPS trend, 90 days to now · 30-day revisions 0 up, 0 down
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 16, 2020 | After the close | — | -1.65 | — |
| Sep 30, 2020 | Time not confirmed | — | -1.65 | — |
| Jun 30, 2020 | Time not confirmed | — | -0.37 | — |
| Mar 31, 2020 | Time not confirmed | — | -0.25 | — |
| Dec 31, 2019 | Time not confirmed | — | -0.07 | — |
| Sep 30, 2019 | Time not confirmed | — | -0.09 | — |
| Jun 30, 2019 | Time not confirmed | — | -0.10 | — |
| Mar 31, 2019 | Time not confirmed | — | -0.07 | — |
| Dec 31, 2018 | Time not confirmed | — | -0.10 | — |
| Sep 30, 2018 | Time not confirmed | — | -0.12 | — |
| Jun 30, 2018 | Time not confirmed | — | -0.10 | — |
| Mar 31, 2018 | Time not confirmed | — | -0.05 | — |
Conversion Labs, Inc. operates as a telemedicine company with a portfolio of online direct-to-consumer brands. The company combines virtual medical treatment with prescription medications and over-the-counter products. Its network of physicians offers telemedicine services and direct-to-consumer pharmacy to consumers across the U.S. Its brand portfolio comprises of brands targeting market segments, such as hair…